ADA Gene - Adenosine Deaminase
Genetic and Functional Insights into ADA Deficiency and Associated Disorders
Gene Information Card
| Symbol | ADA |
|---|---|
| Full Name | Adenosine Deaminase |
| Gene Type | Protein coding |
| Chromosomal Location | 20q13.12 |
| NCBI Gene ID | 100 ncbi.nlm.nih.gov/gene/100 |
| Ensembl ID | ENSG00000196839 |
| UniProt ID | P00813 |
| OMIM ID | 608958 |
| HGNC ID | HGNC:186 |
| Aliases | ADA1, ADAS, ADA2 |
Description
The ADA gene encodes adenosine deaminase, an enzyme involved in purine metabolism that catalyzes the irreversible deamination of adenosine and deoxyadenosine to inosine and deoxyinosine, respectively. Deficiency of this enzyme leads to accumulation of toxic metabolites, primarily causing severe combined immunodeficiency (SCID) due to lymphotoxicity. The gene is located on chromosome 20q13.12 and is expressed in various tissues, with highest levels in lymphoid tissues.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Severe Combined Immunodeficiency (SCID) due to ADA deficiency | Loss-of-function mutations in ADA cause accumulation of deoxyadenosine and dATP, which inhibit ribonucleotide reductase and induce apoptosis in developing T and B lymphocytes. | OMIM #102700; ClinVar; multiple case reports |
| Partial ADA deficiency | Milder mutations result in reduced enzyme activity, leading to late-onset immunodeficiency or autoimmune manifestations. | OMIM #102700; literature review |
| Hemolytic anemia (rare association) | Accumulation of adenosine metabolites may affect erythrocyte metabolism, though direct evidence is limited. | Case reports; ClinVar |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Lymphoid tissues (spleen, lymph node, thymus) | High | High |
| Small intestine | Moderate | Medium |
| Kidney | Moderate | Medium |
| Liver | Low | Low |
| Brain | Low | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| K562 (leukemia) | High | High expression in erythroleukemia cell line |
| HeLa (cervical carcinoma) | Moderate | Moderate expression |
| HEK293 (embryonic kidney) | Low | Low expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.646G>A (p.Gly216Arg) | Missense | Common in ADA-SCID | Loss of function; reduced enzyme activity |
| c.956_960del (p.Leu319Argfs*13) | Frameshift | Rare | Loss of function; truncated protein |
| c.455T>C (p.Leu152Pro) | Missense | Rare | Loss of function; structural instability |
Mutation functional classification
Loss of Function (LOF)
Most ADA mutations are loss-of-function, leading to enzyme deficiency and accumulation of toxic purine metabolites, primarily causing SCID.
Gain of Function (GOF)
No gain-of-function mutations are reported for ADA.
Dominant Negative (DN)
No dominant-negative mutations are reported; ADA deficiency is autosomal recessive.
View complete mutation data:
Gene Ontology (GO)
Pathways
• Purine metabolism (KEGG: hsa00230)
• Adenosine deaminase deficiency (Reactome: R-HSA-1169091)
Protein Summary
Adenosine deaminase (ADA) is a 40.7 kDa monomeric enzyme that catalyzes the deamination of adenosine and deoxyadenosine. It is ubiquitously expressed, with highest levels in lymphoid tissues. The enzyme is critical for purine salvage and detoxification; deficiency leads to accumulation of dATP, which inhibits DNA synthesis and causes lymphotoxicity. ADA is also involved in immune regulation and has been targeted for enzyme replacement therapy in ADA-SCID.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| ADAM9 Knockout HEK293 Cell Line | EDJ-KQ242 | Human | 8754 | Details Get a Quote |
| ADAM17 Knockout HEK293 Cell Line | EDC07796 | Human | 6868 | Details Get a Quote |
| STRADA Knockout HEK293 Cell Line | EDJ-KQ1178 | Human | 92335 | Details Get a Quote |
| ADAR Knockout HEK293 Cell Line | EDJ-KQ2377 | Human | 103 | Details Get a Quote |
| ADAMTSL2 Knockout HEK293 Cell Line | EDJ-KQ2620 | Human | 9719 | Details Get a Quote |
| ADAMTS19 Knockout HEK293 Cell Line | EDJ-KQ3225 | Human | 171019 | Details Get a Quote |
| ADARB1 Knockout HEK293 Cell Line | EDJ-KQ3239 | Human | 104 | Details Get a Quote |
| ADAM12 Knockout HEK293 Cell Line | EDJ-KQ3287 | Human | 8038 | Details Get a Quote |
| ADAMTS5 Knockout HEK293 Cell Line | EDJ-KQ3458 | Human | 11096 | Details Get a Quote |
| ADAMTS12 Knockout HEK293 Cell Line | EDJ-KQ3481 | Human | 81792 | Details Get a Quote |
| ADAM28 Knockout HEK293 Cell Line | EDJ-KQ3666 | Human | 10863 | Details Get a Quote |
| ADAMTS2 Knockout HEK293 Cell Line | EDJ-KQ3934 | Human | 9509 | Details Get a Quote |
| ADAMTS3 Knockout HEK293 Cell Line | EDJ-KQ3935 | Human | 9508 | Details Get a Quote |
| AADAC Knockout HEK293 Cell Line | EDJ-KQ3986 | Human | 13 | Details Get a Quote |
| ADAM8 Knockout HEK293 Cell Line | EDJ-KQ4007 | Human | 101 | Details Get a Quote |
Displaying Records 1 To 15 Of 269 Records
- 1
- 2
- ...
- 16
- 17
- Next Page »